Cargando…
A Network Pharmacology Approach to Estimate Potential Targets of the Active Ingredients of Epimedium for Alleviating Mild Cognitive Impairment and Treating Alzheimer's Disease
BACKGROUND: The present study made use of a network pharmacological approach to evaluate the mechanisms and potential targets of the active ingredients of Epimedium for alleviating mild cognitive impairment (MCI) and treating Alzheimer's disease (AD). METHODS: The active ingredients of Epimediu...
Autores principales: | Gao, Xianwei, Li, Shengnan, Cong, Chao, Wang, Yuejiao, Xu, Lianwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7861915/ https://www.ncbi.nlm.nih.gov/pubmed/33574879 http://dx.doi.org/10.1155/2021/2302680 |
Ejemplares similares
-
Pharmacological and non‐pharmacological interventions to enhance sleep in mild cognitive impairment and mild Alzheimer's disease: A systematic review
por: Blackman, Jonathan, et al.
Publicado: (2020) -
Pharmacological Treatment of Mild Cognitive Impairment as a Prodromal Syndrome of Alzheimer´s Disease
por: Karakaya, Tarik, et al.
Publicado: (2013) -
Estimating attrition in mild-to-moderate Alzheimer’s disease and mild cognitive impairment clinical trials
por: Ritchie, Marina, et al.
Publicado: (2023) -
Are NSAIDs Useful to Treat Alzheimer's Disease or Mild Cognitive Impairment?
por: Imbimbo, Bruno P., et al.
Publicado: (2010) -
Cognitive Blackouts in Mild Cognitive Impairment and Alzheimer's Dementia
por: Adler, Georg, et al.
Publicado: (2018)